Provided by Tiger Trade Technology Pte. Ltd.

INVESCO PHARMACEUTICALS ETF

122.88
+1.891.56%
Post-market: 122.880.00000.00%19:30 EDT
Volume:27.57K
Turnover:3.37M
Market Cap:554.19M
PE:6.37
High:123.25
Open:120.60
Low:120.60
Close:120.99
52wk High:131.68
52wk Low:92.10
Shares:4.51M
Float Shares:4.51M
Volume Ratio:0.76
T/O Rate:0.61%
Dividend:1.13
Dividend Rate:0.92%
EPS(TTM):19.29
EPS(LYR):21.73
ROE:23.89%
ROA:0.60%
PB:1.66
PE(LYR):5.65

Loading ...

Micro-Cap Stock Veraxa Biotech is Down 96% This Year. Can Next-Gen Drug Testing Save It?

Dow Jones
·
Oct 07

AbbVie’s telisotuzumab adizutecan gets two FDA Breakthrough Therapy Designations

TIPRANKS
·
Oct 07

AbbVie Says FDA Grants Breakthrough Therapy Status for ABBV-400 in Metastatic Colorectal Cancer

Reuters
·
Oct 07

Abbvie's Telisotuzumab Adizutecan (Temab-A) Receives Two Breakthrough Therapy Designations from the U.S. FDA for Crc and Nsclc

THOMSON REUTERS
·
Oct 07

Morgan Stanley Adjusts Price Target on Eli Lilly to $1,430 From $1,419

MT Newswires Live
·
Oct 07

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Oct 07

AlzeCure Pharma to Present at Redeye Neurology Day

Reuters
·
Oct 07

Perrigo Co. PLC Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Oct 07

Scotts Miracle-Gro Names Prathima Hegde as CIO

Reuters
·
Oct 07

AbbVie's Epkinly Could Be Preferred Frontline DLBCL Agent, UBS Says

MT Newswires Live
·
Oct 07

SMAIO Signs Sales Agency Agreement with DePuy Synthes for US Market

Reuters
·
Oct 07

Amgen’s AMG 513 Obesity Trial Reaches Phase 1 Completion, Adding a New Angle to the Weight-Loss Drug Race

TIPRANKS
·
Oct 07

Lilly’s New Basal Insulin Candidate Clears Key Early Trial Milestone

TIPRANKS
·
Oct 07

Smaio - Signs Sales Agency Agreement with Depuy Synthes for US Market

THOMSON REUTERS
·
Oct 06

General Medicine Raises $120 Mln to Build the Healthcare Store

Reuters
·
Oct 06

Johnson & Johnson's Innovative Medicines Momentum Offsets MedTech Headwinds, RBC Capital Markets Says

MT Newswires Live
·
Oct 06

General Medicine - Series B Financing Led by Andreessen Horowitz (a16z), with Participation from Matrix, Vxi Capital, Eli Lilly and Company

THOMSON REUTERS
·
Oct 06

European Shares Gain as Genmab Jumps, Bond Yields Retreat

Reuters
·
Oct 06

LIVE Markets-a Health Boost for the STOXX

Reuters
·
Oct 06

Genmab at 3-Year High After Blood Cancer Drug Combination Study Results

Reuters
·
Oct 06